Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The data was collected between 29.05.2026 and 05.06.2026
Multiple international regulatory approvals have followed
The FDA initially added semaglutide injection products for Wegovy and Ozempic to its drug shortage list in March 2022 and August 2022, respectively, and now openly states the shortage has been ongoing for some time. The demand for semaglutide injection products in the United States exceeded the existing supply, and the resulting spur of activity we have seen by 503A compounding pharmacies and 503B outsourcing facilities since then has had an industry-wide impact
Semaglutide also slows gastric emptying, which moderates postprandial glucose excursions and reduces the insulin demand placed on already resistant tissues
Ozempic is also commonly used off-label for weight management in obese and overweight adults
This helps patients create a calorie deficit in their diet, which leads to weight loss when combined with exercise and other healthy lifestyle habits
